Innospec (IOSP) FY2015 results: revenue $1.0 billion, up 5.3% on the year
Innospec Inc. (IOSP) reported revenue of $1.0 billion for fiscal 2015, the year ended 31 December 2015, up 5.3% on the year before. Net income was $120 million, up 42.1%, and diluted earnings per share $4.86. The figures are the company's own, from the 10-K it filed with the SEC on 17 February 2016.
Revenue
$1.0 billion
+5.3% on the year
FY2009FY2015
Operating margin
15.4%
11.7% a year earlier
FY2009FY2015
Net income
$120 million
+42.1% on the year
FY2009FY2015
Diluted EPS
$4.86
+43.8% on the year
FY2009FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
1,012
961
819
+5.3%
Cost of revenue
666
659
564
+1.1%
Gross profit
346
302
255
+14.6%
Gross margin
34.2%
31.4%
31.2%
Research and development
25.3
22.2
21.2
+14.0%
Selling, general and administrative
207
169
142
+22.2%
Operating income
156
112
90.6
+38.9%
Operating margin
15.4%
11.7%
11.1%
Interest expense
2.3
3.8
2.3
-39.5%
Pre-tax income
152
111
92.8
+37.3%
Income tax
32.8
26.8
15.0
+22.4%
Effective tax rate
21.5%
24.2%
16.2%
Net income
120
84.1
77.8
+42.1%
Net margin
11.8%
8.8%
9.5%
Diluted EPS
$4.86
$3.38
$3.22
+43.8%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
118
106
61.3
+11.2%
Capital expenditure
17.6
13.5
11.0
+30.4%
Free cash flow
101
92.8
50.3
+8.4%
Free cash flow margin
9.9%
9.7%
6.1%
Cash from investing
n/a
n/a
-116
Cash from financing
n/a
n/a
113
Depreciation and amortisation
35.2
29.1
20.4
+21.0%
Share-based compensation
3.7
2.6
2.5
+42.3%
Buybacks
15.3
6.9
3.7
+121.7%
Dividends paid
14.9
13.4
12.0
+11.2%
Dividend per share
$0.61
$0.55
$0.50
+10.9%
Diluted shares, weighted
25m
25m
24m
-1.1%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
605
516
409
+17.3%
Non-controlling interest
0.3
0.0
n/a
Debt
132
139
148
-5.6%
Other liabilities
293
345
237
-14.9%
Total liabilities and equity
1,030
1,000
795
+3.0%
Fixed assets
76.0
80.8
60.4
-5.9%
Goodwill
267
276
188
-3.2%
Intangible assets
169
181
127
-6.8%
Investments
4.8
4.7
6.6
+2.1%
Cash and equivalents
137
41.6
80.2
+229.1%
Receivables
137
164
136
-16.4%
Inventory
160
185
159
-13.5%
Other assets
78.9
66.4
38.1
+18.8%
Total assets
1,030
1,000
795
+3.0%
10-K for the year ended 31 December 2015, filed 17 February 2016: the filing.